In this regard, the anti-coagulants that are administered as the standard therapy for APS may also be effective in anti-C9 antibody-positive SN-APS patients because heparin suppressed complement activation in antiphospholipid-antibody treated mice and assisted in preventing pregnancy complication [19]. Here, C9 is linked to autoimmune polyendocrinopathy.